Bionano Genomics, Inc.
BNGO- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001411690
In the last 90 days, Bionano Genomics, Inc. insiders filed 2 open-market purchases and 0 sales; 34 institutions reported holding it in 13F filings for Q2 2026, worth $801.6K in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $9.70K in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 34
- 13F valueReported value at the end of Q2 2026
- $801.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BNGO, Q2 2026
No superinvestor reported holding BNGO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bionano Genomics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 (view filing)4:30 PM ET | Sep 4 | 5 days | Luderer AlbertInterim Chief Executive | PPurchase | +4.00K | $1.21 | +$4.84K | +100.0%8.00K after | |
| Aug 21, 2026 (view filing)4:30 PM ET | Aug 21 | Same day | Luderer AlbertInterim Chief Executive | PPurchase | +4.00K | $1.22 | +$4.86K | New position4.00K after | |
| Jun 14, 2023 (view filing) | Jun 13 | 1 day | Mamuszka HannahDirector | PPurchase | +65.8K | $0.76 | +$50.0K | New position65.8K after | |
| May 16, 2023 (view filing) | May 16 | Same day | Holmlin R. ErikPresident and CEO | PPurchase | +15.0K | $0.64 | +$9.60K | +1.9%806.5K after | |
| May 16, 2023 (view filing) | May 12 | 4 days | Stewart Christopher P.Chief Financial Officer | PPurchase | +50.0K | $0.67 | +$33.5K | +21.6%281.4K after | |
| Aug 17, 2022 (view filing)5:55 PM ET | Aug 15 | 2 days | Linney YvonneDirector | SSale | −20.0K | $3.62 | −$72.4K | −100.0%0 after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Barker David LDirector | PPurchase | +10.0K | $1.60 | +$16.0K | +256.8%13.9K after | |
| Dec 1, 2021 (view filing) | Nov 29 | 2 days | Holmlin R. ErikPresident and CEO | PPurchase | +5.03K | $3.99 | +$20.0K | New position5.03K after | 3 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bionano Genomics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 150,284 | $170.0K | 0.01% | −203,079−57.5% | Reduced |
| Carret Asset Management, LLC | 125,000 | $141.3K | 0.01% | +55,000+78.6% | Added |
| Geode Capital Management, LLC | 89,993 | $101.7K | 0.00% | −77,540−46.3% | Reduced |
| Vanguard Capital Management LLC | 82,388 | $93.1K | 0.00% | +14,279+21.0% | Added |
| Vanguard Fiduciary Trust Co | 51,578 | $58.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 51,100 | $57.7K | 0.00% | +2,400+4.9% | Added |
| Jane Street Group, LLC | 35,728 | $40.4K | 0.00% | +35,728 | New |
| Prudential Financial Inc | 31,600 | $35.7K | 0.00% | +3,600+12.9% | Added |
| Northern Trust Corp | 24,561 | $27.8K | 0.00% | +4,042+19.7% | Added |
| XTX Topco Ltd | 16,295 | $18.4K | 0.00% | +16,295 | New |